Aspartylglucosaminuria: A rare glycoprotein metabolism disorder caused by a deficiency of an enzyme called aspartylglucosaminidase. Patients tend to develop normally during the first few years of life and development continues slowly until adolescence when mental retardation becomes progressively worse. More detailed information about the symptoms, causes, and treatments of Aspartylglucosaminuria is available below.
See full list of 37 symptoms of Aspartylglucosaminuria
Review possible medical complications related to Aspartylglucosaminuria:
Research the causes of these diseases that are similar to, or related to, Aspartylglucosaminuria:
Read more about causes of Aspartylglucosaminuria.
Read more about treatments for Aspartylglucosaminuria
Whenever you go to a hospital or clinic for a major procedure or diagnostic test, one of the many forms you are given to sign is an "informed...
Germs are a fact of life and catching an infectious disease like a cold may seem inevitable. But there are simple ways to protect yourself against...
Health insurance is important to everyone, especially people with chronic conditions like Crohn's disease and ulcerative colitis. Tune in to...
Sleep is necessary to feel refreshed, but now we know sleep actually impacts the way the body functions. Sleeping poorly can affect how often you get...
Prognosis for Aspartylglucosaminuria: Patients tend to survive until mid-adulthood. Mental retardation and disability may be severe by this stage.
More about prognosis of Aspartylglucosaminuria
Read about other experiences, ask a question about Aspartylglucosaminuria, or answer someone else's question, on our message boards:
An inborn error of metabolism caused by deficient activity of the enzyme aspartylglucosaminidase. Clinical manifestations consist of psychomotor retardation, coarse facies, hepatosplenomegaly, ventral hernia, and skeletal abnormalities. - (Source - Diseases Database)
Aspartylglucosaminuria is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Aspartylglucosaminuria, or a subtype of Aspartylglucosaminuria,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Aspartylglucosaminuria as a "rare disease".
Source - Orphanet
» Next page: What is Aspartylglucosaminuria?
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
